These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6245673)

  • 41. Caffeine clearance study in hepatocellular carcinoma.
    Tangkijvanich P; Wittayalertpanya S; Kusonsolboon T; Thong-Ngam D; Mahachai V
    J Med Assoc Thai; 1999 Mar; 82(3):297-303. PubMed ID: 10410486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions.
    Reis H; Bertram S; Pott L; Canbay A; Gallinat A; Baba HA
    Pathol Oncol Res; 2017 Jan; 23(1):33-39. PubMed ID: 27276915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The determination of the viral markers of the hepatitis B virus and protein p53 in liver biopsy samples].
    Lörinczi L; Székely E
    Bacteriol Virusol Parazitol Epidemiol; 1998; 43(3):161-6. PubMed ID: 9932005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
    de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
    Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
    Mun KS; Cheah PL; Baharudin NB; Looi LM
    Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Primary liver cancer accompanied by the circulation of the hepatitis B surface antigen in the blood serum of a 13-year-old child].
    Kupershteĭn AP; Zakrzhevskaia TV; Alaeva LP; Turusheva EA; Pashkova LA
    Pediatriia; 1987; (3):87-8. PubMed ID: 3037476
    [No Abstract]   [Full Text] [Related]  

  • 47. [The HBx protein expression in liver cancer].
    Shi DR
    Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):85-7. PubMed ID: 1655295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Appearance of HBsAg in the liver in cases of hepatocellular carcinoma].
    Szczudrawa J; Urban A; Pomorska I
    Patol Pol; 1984; 35(2):179-89. PubMed ID: 6096796
    [No Abstract]   [Full Text] [Related]  

  • 49. Expression of toll-like receptors in hepatic cirrhosis and hepatocellular carcinoma.
    Sun L; Dai JJ; Hu WF; Wang J
    Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27420991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [HBS Ag-positive hepatocellular cancer (pathomorphologic study)].
    Bardadin K; Kobushevska-Farina M
    Arkh Patol; 1979; 41(8):45-9. PubMed ID: 226040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis.
    Lee S; Mardinoglu A; Zhang C; Lee D; Nielsen J
    Nucleic Acids Res; 2016 Jul; 44(12):5529-39. PubMed ID: 27216817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Granulomas in dysplastic nodules--an unusual morphological finding.
    Phelan S; Nolan N
    Histopathology; 2008 Jul; 53(1):114-5. PubMed ID: 18494782
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatocellular Carcinoma Surveillance: Does Alpha-Fetoprotein Have a Role?
    Mehta A; Singal AG
    Gastroenterology; 2015 Sep; 149(3):816-7. PubMed ID: 26231605
    [No Abstract]   [Full Text] [Related]  

  • 54. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver.
    Turlin B; Juguet F; Moirand R; Le Quilleuc D; Loréal O; Campion JP; Launois B; Ramée MP; Brissot P; Deugnier Y
    Hepatology; 1995 Aug; 22(2):446-50. PubMed ID: 7635411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
    Feng D; Zheng H; Shen M; Cheng R; Yan Y
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):325-8. PubMed ID: 12080637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of ornithine decarboxylase messenger RNA in human hepatocellular carcinoma by in situ hybridization.
    Gan FY; Gesell MS; Moshier JA; Alousi M; Luk GD
    Epithelial Cell Biol; 1992 Jan; 1(1):13-7. PubMed ID: 1339180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain metastasis from hepatocellular carcinoma associated with hepatitis B virus.
    Frati A; Salvati M; Giarnieri E; Santoro A; Rocchi G; Frati L
    J Exp Clin Cancer Res; 2002 Sep; 21(3):321-7. PubMed ID: 12385572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue remodelling in liver diseases.
    Giannelli G; Quaranta V; Antonaci S
    Histol Histopathol; 2003 Oct; 18(4):1267-74. PubMed ID: 12973693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver cirrhosis: lobar differences in disease progression and carcinogenesis.
    Sakon M
    J Gastroenterol; 2000; 35(6):479-80. PubMed ID: 10864359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.